Lin Xichen
Transaction: 08/04/2026
SELL
Change
-839
Price
Not reported
Filing
08/05/2026
Type
SELL
Structure Therapeutics Inc.
GPCR • Biotechnology
$47.34
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$3.44B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 24.81Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:53 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$47.34
Change0.00%
Shares Out72.65M
Market Cap$3.44B
Enterprise Value$2.10B
52W Range15.85 - 94.90
Beta-1.57
P/E-15.99
P/B2.54
P/FCF-16.35
EV/EBITDA-9.30
EV/FCF-9.99
Price$47.34
Change0.00%
Shares Out72.65M
Market Cap$3.44B
Enterprise Value$2.10B
52W Range15.85 - 94.90
Beta-1.57
P/E-15.99
P/B2.54
P/FCF-16.35
EV/EBITDA-9.30
EV/FCF-9.99
Earnings Yield-6.25%
FCF Yield-6.12%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio24.81
Quick Ratio24.81
Target$108.67
Target Upside129.55%
Target Median$111.00
Target Range70.00 - 145.00
Volume327.39K
Avg Volume791.01K
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
81/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 24.81Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 14 analyst votes · 2026-09-05
100/100
Bullish
Bullish
14
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$70.00
Mean
$105.33
Median
$101.00
High
$145.00
Insider Transactions
Recent executive and insider activity
Lin Xichen
Transaction: 08/04/2026
SELL
Change
-11,817
Price
$0.34
Filing
08/05/2026
Type
SELL
Lin Xichen
Transaction: 08/04/2026
SELL
Change
-11,817
Price
Not reported
Filing
08/05/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Lin Xichen | SELL | -839 | Not reported | 08/04/2026 | 08/05/2026 |
| Lin Xichen | SELL | -11,817 | $0.34 | 08/04/2026 | 08/05/2026 |
| Lin Xichen | SELL | -11,817 | Not reported | 08/04/2026 | 08/05/2026 |
| FMR LLC | SELL | -1,367 | Not reported | 07/22/2026 | 07/24/2026 |
| Lin Xichen | SELL | -1,600 | Not reported | 07/14/2026 | 07/15/2026 |
| Lin Xichen | SELL | -23,634 | $0.34 | 07/14/2026 | 07/15/2026 |
| Lin Xichen | SELL | -23,634 | Not reported | 07/14/2026 | 07/15/2026 |
| Lin Xichen | SELL | -7,878 | Not reported | 06/25/2026 | 06/29/2026 |
| Lin Xichen | SELL | -23,634 | $0.34 | 06/25/2026 | 06/29/2026 |
| Lin Xichen | SELL | -23,634 | Not reported | 06/25/2026 | 06/29/2026 |
| WELCH DANIEL G | BUY | +39,453 | $15.00 | 06/17/2026 | 06/18/2026 |
| TETLOW SHARON | BUY | +39,453 | $15.00 | 06/17/2026 | 06/18/2026 |
| DOBMEIER ERIC | BUY | +39,453 | $15.00 | 06/17/2026 | 06/18/2026 |
| Waldstreicher Joanne | BUY | +39,453 | $15.00 | 06/17/2026 | 06/18/2026 |
| LOVE TED W | BUY | +39,453 | $15.00 | 06/17/2026 | 06/18/2026 |
| Russell Angus C. | BUY | +39,453 | $15.00 | 06/17/2026 | 06/18/2026 |
| Lang Matthew | OTHER | 0 | Not reported | 04/15/2026 | 04/23/2026 |
| Lang Matthew | BUY | +184,614 | Not reported | 04/15/2026 | 04/23/2026 |
| Lang Matthew | BUY | +223,776 | $18.08 | 04/15/2026 | 04/23/2026 |
| FMR LLC | SELL | -1,367 | Not reported | 04/14/2026 | 04/16/2026 |